Brainsway Ltd. (BWAY)
24.12
+0.22
(+0.92%)
USD |
NASDAQ |
Feb 20, 16:00
23.93
-0.19
(-0.79%)
After-Hours: 20:00
Brainsway EPS Diluted (Quarterly) : 0.0828 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.223 |
| XTL Biopharmaceuticals Ltd. | -0.0292 |
| Can-Fite BioPharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.573M |
| Revenue (Quarterly) | 13.58M |
| Total Expenses (Quarterly) | 12.00M |
| Enterprise Value | 408.99M |
| Gross Profit Margin (Quarterly) | 75.18% |
| Profit Margin (Quarterly) | 11.59% |
| Earnings Yield | 1.31% |
| Operating Earnings Yield | 0.63% |